SYK
$153.10
Stryker
$.39
.26%
SYK
Earnings Whisper ®
N/A
4th Quarter December 2017
Consensus:  $1.95
Revenue:  $3.41 Bil
Thursday
Jan 25
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, October 26, 2017

What do you expect when SYK reports earnings?
Beat
Meet
Miss

Where is SYK's stock price going from here?
Up
Flat
Down
Stock chart of SYK
Analysts
Summary of analysts' recommendations for SYK
Score
Grade
Pivots
Resistance
$154.14
$153.44
$153.07

$152.37

Support
$152.00
$151.30
$150.93
Tweet
Growth
Description
Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services.
Peers
Abbott LaboratoriesBoston ScientificBecton, DickinsonC. R. BardBaxter InternationalWatersIntegra LifeSciences Holdings3MResMedAbiomed